Parallax Volatility Advisers’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-7,149
Closed -$371K 2997
2021
Q4
$371K Sell
7,149
-5,422
-43% -$280K ﹤0.01% 2275
2021
Q3
$750K Buy
+12,571
New +$791K ﹤0.01% 2095
2021
Q1
Sell
-7,191
Closed -$469K 3342
2020
Q4
$473K Buy
+7,191
New +$423K ﹤0.01% 2512
2020
Q2
Sell
-1,380
Closed -$74.5K 2732
2020
Q1
$70K Sell
1,380
-1,424
-51% -$82.1K ﹤0.01% 2205
2019
Q4
$155K Buy
+2,804
New +$152K ﹤0.01% 2052
2019
Q1
Sell
-63
Closed -$3K 3003
2018
Q4
$3K Buy
63
+20
+47% +$1.14K ﹤0.01% 2626
2018
Q3
$3K Hold
43
﹤0.01% 2368
2018
Q2
$2K Hold
43
﹤0.01% 1926
2018
Q1
$2K Sell
43
-18,804
-100% -$806K ﹤0.01% 2029
2017
Q4
$741K Buy
+18,847
New +$717K ﹤0.01% 1308

Other funds holding EHC

Parallax Volatility Advisers's EHC Position: Q1 2022 in Review

Parallax Volatility Advisers sold out of Encompass Health (EHC) in Q1 2022, closing a stake of 7,149 shares — an estimated $371K sold.

Parallax Volatility Advisers first reported a position in EHC in Q4 2017 and held it in 10 quarters. The position peaked at $750K in Q3 2021. 406 funds tracked by Wall St. Rank hold EHC as of Q1 2022.

  • Parallax Volatility Advisers reported no remaining Encompass Health position as of Q1 2022 after selling out during the quarter.
  • Parallax Volatility Advisers sold 7,149 Encompass Health shares in Q1 2022, an estimated $371K.
  • Parallax Volatility Advisers first reported a position in Encompass Health in Q4 2017 and held it in 10 quarters.
  • Parallax Volatility Advisers's Encompass Health position peaked at $750K in Q3 2021.
  • 406 funds tracked by Wall St. Rank held Encompass Health as of Q1 2022.

Based on Parallax Volatility Advisers's 13F filing for Q1 2022, filed 16 May 2022.